IP Library › Assignment 020616/0412
Patent Assignment
Reel/Frame 020616/0412

Merger

Recorded: 2008-03-07 Pages: 10
Assignor
THROMB-X N.V.
Executed: 2007-07-19
Assignee
THROMBOGENICS N.V.
HERESTRAAT 49, LEUVEN, B-3000, BELGIUM
Covered Property (1)
Novel Anti-Plgf Antibody
Patent: 7,875,704 →
Application: 11/909,604 →
Publication: US 2008/0193455
Related Assignments (5)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest Feb 22, 2008
From: COLLEN, DESIRE
To: LIFE SCIENCES RESEARCH PARTNERS VZW
Reel/Frame 020548/0052 →
Assignment of Assignor's Interest Feb 22, 2008
From: CARMELIET, PETER
To: VLAAMS INTERUNIVERSITAIR INSTITUUT VOOR BIOTECHNOLOGIE VZW
Reel/Frame 020548/0578 →
Assignment of Assignor's Interest Feb 22, 2008
From: STASSEN, JEAN-MARIE
To: THROMB-X N.V.
Reel/Frame 020548/0614 →
Change of Name Mar 7, 2008
From: D. COLLEN RESEARCH FOUNDATION VZW
To: LIFE SCIENCES RESEARCH PARTNERS VZW
Reel/Frame 020619/0826 →
Change of Name Feb 13, 2019
From: THROMBOGENICS N.V.
To: OXURION NV
Reel/Frame 049255/0733 →